LY341495 aplatin Ingenol Mebutate was approved for

Ingenol Mebutate was approved for the topical treatment of actinic keratosis

highly selective 5-HT(1F) receptor agonist (K1=2

Although Nutlin-3 also inhibits the growth and viability of human skin (1043SK) and mouse embryo (NIH/3T3) with IC50 of 2

Solubility: DMSO : 100 mg/mL (189

Administered 30 minutes after gemcitabine

LY341495 aplatin Ingenol Mebutate was approved forLY 341495 is a potent and selective orthosteric antagonist for the group II metabotropic glutamate receptors (mGluR2 3). Ki IC50 values of LY 341495 are 2. 3, 1. 3, 173, 990, 6800, 8200 and 22000 nM for human mGlu2, mGlu3, mGlu8 , mGlu7a, mGlu1a, mGlu5a and mGlu4a receptors respectively. It is used in scientific research in several different areas, showing antidepressant effects in animal models, increasing the behavioural effects of hallucinogenic